Citations 2

Sorafenib for Advanced and Refractory Desmoid Tumors

New England Journal of Medicine | December 19, 2018 | Volume: 379 | Issue: 25 | Pages: 2417-2428

10.1056/nejmoa1805052 | PMID 30575484

Phase III, randomized, double blind, placebo-controlled trial of sorafenib in desmoid tumors (Alliance A091105).

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 11500-11500

10.1200/jco.2018.36.15_suppl.11500